News

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to approve the world’s only twice-a-year injectable form of PrEP.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Summer break brings some new concerns for parents, the medical workers helping the nation's aging homeless population, a ...
The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective.
The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...